22 Stocks Moving In Monday's Pre-Market Session

Gainers

• Novocure Ltd NVCR rose 40.1 percent to $11.35 in pre-market trading after the company disclosed that the two-year survival rate for GBM Patients increased from 30% to 43% for patients treated with Optune + temozolomide versus temozolomide alone at the AACR 2017.
• Steadymed Ltd STDY shares rose 31 percent to $7.60 in pre-market trading. Cardiome's partner SteadyMed received a favorable ruling in USPTO Inter Partes Review in validity of U.S. Patent No. 8,497,393.
• Cellect Biotechnology Ltd. APOP rose 15.6 percent to $9.94 in pre-market trading after the company reported an European patent grant.
• Dynavax Technologies Corporation DVAX rose 15.1 percent to $6.85 in pre-market trading after the company disclosed that the PDUFA date for HEPLISAV-B will remain unchanged.
• BioCryst Pharmaceuticals, Inc. BCRX shares rose 9.6 percent to $9.21 in pre-market trading after the company reported that Mundipharma has received approval for Mundesine in Japan.
• BiondVax Pharmaceuticals Ltd (ADR) BVXV rose 9.5 percent to $6.35 in pre-market trading after declining 6.90 percent on Friday.
• Eleven Biotherapeutics Inc EBIO rose 9.1 percent to $2.40 in pre-market trading. Eleven Biotherapeutics presented new preclinical data supporting potential of the company's locally and systematically-administered drug candidates at the AACR 2017.
• Infinity Pharmaceuticals Inc. INFI rose 8.4 percent to $3.50 in pre-market trading. Infinity Pharmaceuticals presented updated Phase 1 data for IPI-549 at the AACR 2017.
• Matinas BioPharma Holdings Inc MTNB rose 8.3 percent to $3.00 in pre-market trading. Matinas BioPharma reported a FY16 loss of $0.21 per share.
• Medigus Ltd. MDGS shares rose 7.1 percent to $3.30 in pre-market trading after dropping 3.14 percent on Friday.
• AerCap Holdings N.V. AER rose 6.3 percent to $48.86 in pre-market trading after gaining 0.13 percent on Friday.
• Kite Pharma Inc KITE rose 5.8 percent to $83.01 in pre-market trading. Kite presented ongoing response rate in plenary session from its pivotal CAR-T trial of Axicabtagene Ciloleucel in patients with aggressive non-hodgkin lymphoma at AACR 2017.
• Nabors Industries Ltd. NBR shares rose 5.1 percent to $13.74 in pre-market trading after gaining 0.15 percent on Friday.
• Syneron Medical Ltd. ELOS shares rose 4.7 percent to $11.05 in pre-market trading. Syneron Candela agreed to be acquired by funds advised by Apax Partners for $11 per share in cash,

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• United Therapeutics Corporation UTHR dropped 9.1 percent to $123.00 in pre-market trading after the company disclosed that the US launch of RemoSynch will be delayed due to regulatory delays.
• Acorda Therapeutics Inc ACOR shares fell 5 percent to $19.95 in the pre-market trading session after declining 21.50 percent on Friday.
• Dicerna Pharmaceuticals Inc DRNA shares fell 4.4 percent to $3.25 in pre-market trading after climbing 25.93 percent on Friday.
• Conatus Pharmaceuticals Inc CNAT fell 3 percent to $5.60 in pre-market trading after declining 2.53 percent on Friday.
• DRDGOLD Ltd. (ADR) DRD fell 2.7 percent to $4.78 in pre-market trading after rising 1.87 percent on Friday.
• DBV Technologies SA - ADR DBVT shares fell 2.4 percent to $34.39 in pre-market trading after gaining 1.00 percent on Friday.
• Accenture Plc ACN fell 2.2 percent to $117.22 in pre-market trading. Goldman Sachs downgraded Accenture from Neutral to Sell and lowered the price target from $125.00 to $110.00.
• Deutsche Bank AG (USA) DB fell 2.1 percent to $16.81 in pre-market trading after dropping 0.58 percent on Friday.